A Prospective Registry to Assess the Effectiveness and Local Tolerability of Intravesical Valrubicin in Subjects With Non-muscle Invasive Bladder Cancer (NMIBC)
N/A
The purpose of this study is to observe and describe the effectiveness and ...
Status
Terminated
Location
BCG Oncology
Start Date
2011-05
Trial ID
NCT01314664
Surgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
PHASE3
RATIONALE: Transurethral resection is a less invasive type of surgery for b...
Intravesical AD 32 (Valrubicin) in Patients With Carcinoma in Situ (CIS) of the Bladder Who Have Failed or Have Recurrence Following Treatment With Bacillus Calmette-guerin (BCG)
PHASE2
This is a Phase II/Phase III study of intravesical AD 32 (valrubicin) in pa...
Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder
PHASE3
This is a Phase 3b open-label, randomized, parallel-arm, multicenter study ...